U
Rize Oncology Inc. RZONF
$0.16 $0.159639,900.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Total Cash And Short-Term Investments -31.11% 20.28% -6.31% -17.68% -8.13%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 637.29% -39.16% -32.06% 4,786.67% -96.83%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -14.12% 17.36% -8.02% -11.94% -11.10%

Total Current Assets -14.12% 17.36% -8.02% -11.94% -11.10%
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets -14.12% 17.36% -8.02% -11.94% -11.10%

Total Accounts Payable -57.84% 171.09% 26.72% -57.74% 73.73%
Total Accrued Expenses -- -- -- -- --
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities -59.57% 182.65% 26.72% -57.74% 42.23%

Total Current Liabilities -59.57% 182.65% 26.72% -57.74% 42.23%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -59.57% 182.65% 26.72% -57.74% 42.23%

Common Stock & APIC 8.41% 0.01% 0.34% 0.03% 0.06%
Retained Earnings -5.49% -3.65% -2.84% -2.44% -3.37%
Treasury Stock & Other -397.81% 142.33% 6.34% -5.94% -18.30%
Total Common Equity -10.72% 12.44% -8.77% -9.84% -12.61%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -10.72% 12.44% -8.77% -9.84% -12.61%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -10.72% 12.44% -8.77% -9.84% -12.61%